Morphine Dinicotinate — Competitive Intelligence Brief

Morphine Dinicotinate (NICOMORPHINE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Opioid Agonist. Area: Pain.

phase 2 Opioid Agonist Pain Small molecule

Target snapshot

Morphine Dinicotinate (NICOMORPHINE). NICOMORPHINE works by binding to opioid receptors in the brain, producing feelings of pain relief and potentially other effects.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Morphine Dinicotinate TARGET	NICOMORPHINE		phase 2	Opioid Agonist
BENZHYDROCODONE	BENZHYDROCODONE		marketed	Opioid analgesic combination; full mu-opioid agonist with non-opioid analgesic	Mu-opioid receptors (primary); delta and kappa opioid receptors (secondary); central nervous system pain pathways	2018-01-01
Nucynta	TAPENTADOL	Collegium Pharm Inc	marketed	Opioid Agonist	Mu-type opioid receptor	2008-01-01
Alfenta	ALFENTANIL	Rising	marketed	Opioid Agonist	Mu-type opioid receptor	1986-01-01
Dilaudid-Hp	Hydromorphone Hydrochloride	Fresenius Kabi	marketed	Opioid agonist	Mu-opioid receptor	1984-01-01
Sufenta Preservative Free	SUFENTANIL	Rising	marketed	Opioid Agonist	Mu-type opioid receptor	1984-01-01
Dilaudid-Hp	HYDROMORPHONE	Fresenius Kabi	marketed	Opioid Agonist	mu-opioid receptor	1984-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Opioid Agonist class)

1. · 4 drugs in this class
2. Rising · 2 drugs in this class
3. Pfizer · 2 drugs in this class
4. Endo · 1 drug in this class
5. Fresenius Kabi · 1 drug in this class
6. Specgx Llc · 1 drug in this class
7. Teva · 1 drug in this class
8. Bausch Health · 1 drug in this class
9. Collegium Pharm Inc · 1 drug in this class